Endothelial cells at inflammatory sites as target for therapeutic intervention

Endothelium: Journal of Endothelial Cell Research

Volumn 9, Issue 3, 2002, Pages 161-171

  Koning, Gerben A ^a   Schiffelers, Raymond M ^a   Storm, Gert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adhesion molecules; Angiogenesis; Drug targeting; Endothelial cells; Inflammation; Leukocyte recruitment

Indexed keywords

ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CORTICOSTEROID DERIVATIVE; CYTOKINE; DEXAMETHASONE; DRUG CARRIER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLIPOSOME; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 4; L SELECTIN; LIPOSOME; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; PADGEM PROTEIN; SELECTIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1 ANTIBODY;

ANGIOGENESIS; CELL ADHESION; CELL POPULATION; CELL SPECIFICITY; CHRONIC INFLAMMATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; ENDOTHELIUM CELL; ENTERITIS; EXTRACELLULAR MATRIX; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE AGGREGATION; METABOLIC REGULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; TARGET CELL; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION MOLECULES; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOGLOBULINS; INFLAMMATION; INTEGRINS; MODELS, BIOLOGICAL; SELECTINS;

EID: 0036037475     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320213631     Document Type: Review

References (95)

1. Specific targeting of adriamycin conjugates with monoclonal antibodies to hepatoma associated antigens to intrahepatic tumors in athymic mice
2. Liposomes: Opportunities in drug delivery
3. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
4. Apical topography and modulation of ICAM-1 expression on activated endothelium
5. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
6. Selectins as new targets for immunoliposome-mediated drug delivery. A potential way of anti-inflammatory therapy
7. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides
8. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice
9. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins
10. Adhesion molecules: A new target for immunoliposome-mediated drug delivery
11. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo
12. Defining therapeutic targets by using adenovirus: Blocking NF-kappa B inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators
13. Inhibition of nuclear factor-kappa B nuclear localization reduces human E-selectin expression and the systemic inflammatory responses
14. Glucocorticoids inhibit E-selectin expression by targeting NF-kappa B and not ATF/c-Jun
15. Acceleration and increased severity of collagen-induced arthritis in P-selectin mutant mice
16. A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1
17. Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin directed immunoconjugate
18. Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation
19. Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin pro-drug therapy
20. VCAM-1/α4-integrin adhesion pathway: Therapeutic target for allergic inflammatory disorders
21. Biological molecule-impregnated polyester: An in vivo angiogenesis study
22. A cell-surface molecule involved in organ-specific homing of lymphocytes
23. Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature
24. Engineering liposomes for drug delivery: Progress and problems
25. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation
26. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leukocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1))
27. Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin
28. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses
29. Novel crosslinking methods to design hydrogels
30. Pharmacological modulation of cell adhesion molecules
31. The role of multivalency in antibody mediated liposome targeting
32. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature
33. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models
34. The codenpence of angiogenesis and chronic inflammation
35. Adhesion molecule expression in human synovial tissue
36. Differential roles of selectins and the alpha4-integrin in acute, subacute, and chronic leukocyte recruitment in vivo
37. Investigation of the cellular uptake of E-selectin-targeted immunoliposomes by activated human endothelial cells
38. Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity
39. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues
40. Preparation and functional evaluation of RGD-modified proteins as αvβ 3 integrin directed therapeutics
41. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells
42. Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases
43. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine (FUdR) from immunoliposomes to colon cancer cells
44. A simplified method for growth of human microvascular endothelial cells results in decreased senescence and continued responsiveness to cytokines and growth factors
45. Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape
46. Signalling by integrin receptors
47. Molecular mechanisms of leukocyte recruitment in the inflammatory process
48. Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells
49. Immunoliposomes for the targeted delivery of antitumor drugs
50. Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells
51. Adhesion molecules in autoimmune disease
52. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function
53. Mechanisms of splenic clearance of blood cells and particles: Towards development of new splenotropic agents
54. Adhesion molecules: A rheumatological perspective
55. Stabilized plasmid-lipid particles: Pharmacokinetics and plasmid delivery to distal tumors following intravenous injection
56. A peptide carrier for the delivery of biologically active proteins into mammalian cells
57. Migration of leukocytes across endothelium and beyond: Molecules involved in the transmigration and fate of monocytes
58. Cardioprotection by liposome-conjugated sialyl Lewis x-oligosaccharide in myocardial ischaemia and reperfusion injury
59. Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy
60. Neutralization of TNF by the antibody cA2 reveals differential regulation of adhesion molecule expression on TNF-activated endothelial cells
61. Monocytes induce E-selectin gene expression in endothelial cells: Role of CD11/CD18 and extracellular matrix proteins
62. Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli
63. Angiogenesis inhibition suppresses collagen arthritis
64. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis
65. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: An additional mechanism for their anti-inflammatory and immunosuppressive effect
66. Monoclonal antibody blockade of L-selectin inhibits mononuclear leukocyte recruitment to inflammatory sites in vivo
67. Recombinant lipoproteins: Lipoprotein-like lipid particles for drug targeting
68. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents
69. VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its alpha 4 beta 1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes
70. On the mechanism of hepatic transendothelial passage of large liposomes
71. Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: Influence of liposome characteristics
72. Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue
73. Streptococcal cell wall-induced arthritis: Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2
74. The NF kappa B inhibitory peptide, I kappa B alpha, prevents human vascular smooth muscle proliferation
75. Liposomal delivery of purified inhibitory-kappa B alpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation
76. Residues throughout the cytoplasmic domain affect the internalization efficiency of P-selectin
77. Lymphocyte adhesion molecules in autoimmune rheumatic diseases: Basic issues and clinical expectations
78. Antisense oligonucleotides to the p65 subunit of NF-κB block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes
79. x and PSGL-1
80. Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system
81. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist
82. Colloidal systems for tumor targeting
83. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability
84. Cellular adhesion molecules in rheumatoid arthritis: Regulation by cytokines and possible clinical importance
85. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
86. Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes
87. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo
88. Mechanisms that regulate the function of the selectins and their ligands
89. Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis
90. Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation
91. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis
92. An electron microscopic study of the fenestrated endothelial cell lining of rat liver sinusoids
93. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokine, vascularization, and bony destruction in rat adjuvant-induced arthritis
94. Leukocyte transendothelial migration: Orchastrating the underlying molecular machinery
95. Binding and internalization of an LFA-1-derived cyclic peptide by ICAM receptors on activated lymphocyte: A potential ligand for drug targeting to ICAM-1-expressing cells